R4 Ballot #1 #2 (Mixed Normative/Trial use)

This page is part of the FHIR Specification (v3.3.0: (v3.5.0: R4 Ballot 2). #2). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see the Directory of published versions

Medicinalproductingredient-example.json

Biomedical Research and Regulation Work Group Maturity Level : N/A Ballot Status : Informative Compartments : Not linked to any defined compartments

Raw JSON ( canonical form + also see JSON Format Specification )

Example of medicinalproductingredient

{
  "resourceType": "AdverseEvent",

  "resourceType": "MedicinalProductIngredient",

  "id": "example",
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: example</p><p><b>identifier</b>: 49476534</p><p><b>actuality</b>: actual</p><p><b>event</b>: This was a mild rash on the left forearm <span>(Details : {SNOMED CT code '304386008' = 'O/E - itchy rash', given as 'O/E - itchy rash'})</span></p><p><b>subject</b>: <a>Patient/example</a></p><p><b>date</b>: 29/01/2017 12:34:56 PM</p><p><b>seriousness</b>: Non-serious <span>(Details : {http://hl7.org/fhir/adverse-event-seriousness code 'Non-serious' = 'Non-serious', given as 'Non-serious'})</span></p><p><b>severity</b>: Mild <span>(Details : {http://hl7.org/fhir/adverse-event-severity code 'Mild' = 'Mild', given as 'Mild'})</span></p><p><b>recorder</b>: <a>Practitioner/example</a></p><h3>SuspectEntities</h3><table><tr><td>-</td><td><b>Instance</b></td></tr><tr><td>*</td><td><a>Medication/example</a></td></tr></table></div>"
  },
  "identifier": {
    "system": "http://acme.com/ids/patients/risks",
    "value": "49476534"
  },
  "actuality": "actual",
  "event": {
    "coding": [
      {
        "system": "http://snomed.info/sct",
        "code": "304386008",
        "display": "O/E - itchy rash"
      }
    ],
    "text": "This was a mild rash on the left forearm"
  },
  "subject": {
    "reference": "Patient/example"
  },
  "date": "2017-01-29T12:34:56+00:00",
  "seriousness": {
    "coding": [
      {
        "system": "http://hl7.org/fhir/adverse-event-seriousness",
        "code": "Non-serious",
        "display": "Non-serious"
      }
    ]

    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative with Details</b></p><p><b>id</b>: example</p><p><b>role</b>: ActiveBase <span>(Details : {http://ema.europa.eu/example/ingredientRole code 'ActiveBase' = 'ActiveBase)</span></p><p><b>manufacturer</b>: <a>Organization/example</a></p><h3>SpecifiedSubstances</h3><table><tr><td>-</td><td><b>Code</b></td><td><b>Group</b></td></tr><tr><td>*</td><td>equixabanCompanyequixaban1 <span>(Details : {http://ema.europa.eu/example/specifiedSubstance code 'equixabanCompanyequixaban1' = 'equixabanCompanyequixaban1)</span></td><td>2 <span>(Details : {http://ema.europa.eu/example/specifiedSubstanceGroup code '2' = '2)</span></td></tr></table><blockquote><p><b>substance</b></p><p><b>code</b>: EQUIXABAN <span>(Details : {http://ema.europa.eu/example/substance code 'EQUIXABAN' = 'EQUIXABAN)</span></p><h3>Strengths</h3><table><tr><td>-</td></tr><tr><td>*</td></tr></table></blockquote></div>"

  },
  "severity": {

  "role": {

    "coding": [
      {
        "system": "http://hl7.org/fhir/adverse-event-severity",
        "code": "Mild",
        "display": "Mild"

        "system": "http://ema.europa.eu/example/ingredientRole",
        "code": "ActiveBase"

      }
    ]
  },
  "recorder": {
    "reference": "Practitioner/example"
  },
  "suspectEntity": [

  "manufacturer": [

    {
      "instance": {
        "reference": "Medication/example"

      "reference": "Organization/example"
    }
  ],
  "specifiedSubstance": [
    {
      "code": {
        "coding": [
          {
            "system": "http://ema.europa.eu/example/specifiedSubstance",
            "code": "equixabanCompanyequixaban1"
          }
        ]
      },
      "group": {
        "coding": [
          {
            "system": "http://ema.europa.eu/example/specifiedSubstanceGroup",
            "code": "2"
          }
        ]

      }
    }
  ]

  ],
  "substance": {
    "code": {
      "coding": [
        {
          "system": "http://ema.europa.eu/example/substance",
          "code": "EQUIXABAN"
        }
      ]
    },
    "strength": [
      {
        "presentation": {
          "numerator": {
            "value": 2.5,
            "unit": "mg"
          },
          "denominator": {
            "value": 1,
            "unit": "{tablet}"
          }
        }
      }
    ]
  }

}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.